Use of Lung Cancer Screening Tests in the United States: Results from the 2010 National Health Interview Survey

Background: Before evidence of efficacy, lung cancer screening was being ordered by many physicians. The National Lung Screening Trial (NLST), which showed a 20% reduction in lung cancer mortality among those randomized to receive low-dose computed tomography (LDCT), will likely lead to increased screening use. Methods: We estimated the prevalence of chest X-ray and CT use in the United States using data from the 2010 National Health Interview Survey (NHIS). Subjects included 15,537 NHIS respondents aged ≥40 years without prior diagnosis of lung cancer. Estimates of the size of the U. S. population by age and smoking status were calculated. Multivariate logistic regression examined predictors of test use adjusting for potential confounders. Results: Twenty-three percent of adults reported chest X-ray in the previous year and 2.5% reported chest X-ray specifically to check for lung cancer; corresponding numbers for chest CT were 7.5% and 1.3%. Older age, black race, male gender, smoking, respiratory disease, personal history of cancer, and having health insurance were associated with test use. Approximately, 8.7 million adults in the United States would be eligible for LDCT screening according to NLST eligibility criteria. Conclusions and Impact: Monitoring of trends in the use of lung screening tests will be vital to assess the impact of NLST and possible changes in lung cancer screening recommendations and insurance coverage in the future. Education of patients by their physicians, and of the general public, may help ensure that screening is used appropriately, in those most likely to benefit. Cancer Epidemiol Biomarkers Prev; 21(7); 1049–59. ©2012 AACR.

[1]  G. Petersen,et al.  Epidemiology, screening, and prevention of lung cancer. , 1994, Current opinion in oncology.

[2]  Linda Humphrey,et al.  Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force , 2004, Annals of Internal Medicine.

[3]  A. Mehta,et al.  CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax risk , 2004 .

[4]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[5]  Peter B Bach,et al.  Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[6]  U. P. S. T. Force.  Lung Cancer Screening: Recommendation Statement , 2004, Annals of Internal Medicine.

[7]  R. Choplin,et al.  Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. , 1999, Radiology.

[8]  G. Byrnes,et al.  Screening for lung cancer. , 2004, The Cochrane database of systematic reviews.

[9]  L. Brody,et al.  Outpatient treatment of iatrogenic pneumothorax after needle biopsy. , 1997, Radiology.

[10]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.

[11]  Colleen Bouzan,et al.  Cost-Effectiveness of Computed Tomography Screening for Lung Cancer in the United States , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  Jackline L Vickerie,et al.  Summary health statistics for the U.S. population: National Health Interview Survey, 2010. , 2011, Vital and health statistics. Series 10, Data from the National Health Survey.

[13]  Ravi Murthy,et al.  Small (, 2005, Radiology.

[14]  P. F. Adams,et al.  Summary health statistics for the U.S. population: National Health Interview Survey, 2007. , 2008, Vital and health statistics. Series 10, Data from the National Health Survey.

[15]  Bernard Maitre,et al.  Screening by Chest Radiograph and Lung Cancer Mortality : The Prostate , Lung , Colorectal , and Ovarian ( PLCO ) Randomized Trial , 2022 .

[16]  J. Reich.  A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening , 2008, Thorax.

[17]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[18]  S. Feig,et al.  Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. , 2010, Radiologic clinics of North America.

[19]  D. Miglioretti,et al.  Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. , 2009, Archives of internal medicine.

[20]  David J Brenner,et al.  Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. , 2004, Radiology.

[21]  H. Brenner,et al.  Cost-effectiveness of Colorectal Cancer Screening , 2011, Epidemiologic reviews.

[22]  J. Birkmeyer,et al.  Operative mortality with elective surgery in older adults. , 2001, Effective clinical practice : ECP.

[23]  P. F. Adams,et al.  Summary health statistics for the U.S. population: National Health Interview Survey, 2008. , 2009, Vital and health statistics. Series 10, Data from the National Health Survey.

[24]  P. Marcus,et al.  Lung Cancer Screening Practices of Primary Care Physicians: Results From a National Survey , 2012, The Annals of Family Medicine.

[25]  C. Begg,et al.  The influence of hospital volume on survival after resection for lung cancer. , 2001, The New England journal of medicine.

[26]  P. Marcus,et al.  U.S. primary care physicians' lung cancer screening beliefs and recommendations. , 2010, American journal of preventive medicine.

[27]  E. Bergstralh,et al.  Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. , 2006, Journal of the National Cancer Institute.

[28]  D. M. Parkin,et al.  Lack of benefit from semi‐annual screening for cancer of the lung: Follow‐up report of a randomized controlled trial on a population of high‐risk males in czechoslovakia , 1990, International journal of cancer.

[29]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[30]  D. Habbema,et al.  Cervical cancer screening in the United States and the Netherlands: a tale of two countries. , 2012, The Milbank quarterly.

[31]  J. Peres.  Lung cancer screening: ready for prime time? , 2011, Journal of the National Cancer Institute.

[32]  W T McGivney,et al.  The National Comprehensive Cancer Network , 1998, Cancer.

[33]  E. Bergstralh,et al.  Screening for lung cancer. A critique of the mayo lung project , 1991, Cancer.

[34]  T. Brennan,et al.  Direct-to-consumer marketing of high-technology screening tests. , 2002, The New England journal of medicine.

[35]  Jeannine S. Schiller,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2001. , 2004, Vital and health statistics. Series 10, Data from the National Health Survey.

[36]  M. Melamed,et al.  Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited , 2009, Cancer.

[37]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[38]  R. Hayes,et al.  Utilization of surveillance colonoscopy in community practice. , 2010, Gastroenterology.

[39]  F. Hirsch,et al.  Lung Cancer: A multidisciplinary Approach to Diagnosis and Management , 2010 .

[40]  J. Gohagan,et al.  Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. , 2011, JAMA.

[41]  G. Bepler,et al.  Screening for lung cancer. , 2000, The New England journal of medicine.

[42]  Jeannine S. Schiller,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2010. , 2012, Vital and health statistics. Series 10, Data from the National Health Survey.

[43]  E. Feuer,et al.  Bias Associated With Self-Report of Prior Screening Mammography , 2009, Cancer Epidemiology Biomarkers & Prevention.